ALUR
Allurion Technologies, Inc.
$5.50
+0.70 (+14.58%)
At close · Jul 2
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's recurring losses from operations incurred since inception, its expectation of continuing operating losses for the foreseeable future, the potential need to raise additional capital to finance its future operations, and noncompliance with certain financial covenants under its credit facilities, the Company has concluded that there is substantial doubt about its ability to continue as a going concern for a period of one year from the date that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.”View the 10-Q filed May 15, 2026
Market Cap
$60.03M
Shares
15,006,253
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.50
Open$4.38
Day$4.38–5.95
52W$2.67–49.95
Avg vol 30d7K
Short int62K · 0.4% float · 1.0d
Short vol0%
Last earningsJan 12, 2026
DataAug 2023–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Strong Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−70% below
−
Price vs 50-day avg
−46% below
◦
RSI (14)
40 · neutral
−
MACD trend
negative
−
52-week position
6% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $10 › 200d $18 — 200d above 50d
−
Institutional flow
-96% holders QoQ
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.41% of float · ▼ -11.3% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — near 1-yr low, contrarian setup
Fundamentals
Weak
−
Revenue growth
−53% Y/Y
+
Gross margin
63%, contracting
−
EPS growth
−19% Y/Y
−
Free cash flow
$-29.6M
+
Balance sheet
net cash $5.4M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−70% below
Bearish
Price vs 50-day avg
−46% below
Bearish
RSI (14)
40 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
6% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $10 › 200d $18 — 200d above 50d
Institutional flow
Distributing
-96% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.41% of float · ▼ -11.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $3
Now $6 · 6%
52-wk high $50
vs 200-day avg -70%
vs 50-day avg -46%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALUR
this stock
Allurion Technologies, Inc.
|
$60.03M | -70.2% | -39.9% | — | 0.4% |
|
ABT
Abbott Laboratories
|
$166.57B | -23.3% | +5.7% | 26.8 | 1.3% |
|
SYK
Stryker Corp
|
$124.49B | -7.4% | +11.2% | 37.6 | 1.6% |
|
MDT
Medtronic plc
|
$106.32B | -12.8% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.62B | -53.2% | +5.5% | 19.0 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALUR | -0.9% | -57.1% | -78.4% | +37.5% | -70.2% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -2.3% | -55.9% | -86.5% | +37.8% | -79.4% |